• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

TRIM33 Gene Activity Linked to Aggressive Breast Cancer

by
November 9, 2026
in Cancer, Health
Reading Time: 3 mins read
0
TRIM33 Gene Activity Linked to Aggressive Breast Cancer

TRIM33 Gene Activity Linked to Aggressive Breast Cancer

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A small study conducted in India has identified a potential epigenetic mechanism associated with triple-negative breast cancer (TNBC), a particularly aggressive subtype of the disease. Researchers from the Indira Gandhi Institute of Medical Sciences in Patna and the All India Institute of Medical Sciences in New Delhi found that a specific gene, TRIM33, was more active in tumor tissues compared to healthy breast tissue from the same patients.

The disease is frequently associated with high rates of recurrence, metastasis, and resistance to standard treatments. While members of the tripartite motif-containing protein family, or TRIM proteins, are known to regulate tumor growth through their roles in cell proliferation, invasion, and migration, the specific role of TRIM33 in TNBC had not been well understood. Previous research indicated that TRIM33 could act as either a tumor suppressor or a tumor promoter depending on the cancer context, partly due to its involvement in TGF-β-related signaling pathways. However, data regarding its expression patterns and epigenetic regulation in Indian patients with TNBC were previously lacking.

To investigate this gap, the research team included twenty-eight patients with histologically confirmed triple-negative breast cancer in their study. Tissue samples were collected at the time of surgery, consisting of the tumor tissue and paired adjacent non-tumor breast tissue from each patient. The study focused on measuring both the mRNA and protein levels of TRIM33, as well as the methylation status of its promoter region.

The researchers employed several laboratory techniques to assess these molecular markers. Western blotting and immunohistochemistry were utilized to detect TRIM33 protein levels, offering insights into the actual protein presence within the tissue. To determine the epigenetic regulation of the gene, methylation-specific PCR, or MS-PCR, was applied to assess the methylation status of the TRIM33 promoter.

The results showed that TRIM33 expression was generally increased in the TNBC tissue compared to the paired adjacent non-tumor tissue. Specifically, increased TRIM33 mRNA expression was observed in 19 of the 28 cases, representing 67.9% of the patients. At the protein level, elevated TRIM33 expression was detected in 16 of the 28 cases, or 57.1%.

An unmethylated or hypomethylated pattern of the TRIM33 promoter was observed in 22 of the 28 cases, accounting for 78.6% of the patients.

The researchers also examined the relationship between TRIM33 expression and the clinicopathological characteristics of the patients. TRIM33 protein expression showed significant associations with several factors, including the clinical stage of the cancer. Similarly, the promoter methylation status was associated with selected clinicopathological parameters. These associations suggest that the level of TRIM33 expression and its epigenetic regulation may be linked to the progression and severity of the disease. However, the study did not establish a causal relationship between TRIM33 hypomethylation and tumor progression, but rather identified a statistical association within the sample.

The study has several limitations that must be considered when interpreting the results. The sample size was relatively small, consisting of only 28 patients, which limits the statistical power and generalizability of the findings. The study was conducted in a specific geographic and demographic context, involving Indian patients, and it is unclear whether these findings would be consistent in other populations. The authors noted that these findings warrant validation in larger patient cohorts to confirm the potential role of epigenetic regulation of TRIM33 in TNBC.

Subject of Research: Epigenetic regulation of TRIM33 in triple-negative breast cancer

Article Title: Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients

Article References: Chaudhary, A., Kumar, M., Akhtar, M. J., Massey, S., Mohan, L., & Ahmad, M. M. (2026). Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients. Frontiers in Oncology, 16, Article 1973520. https://doi.org/10.3389/fonc.2026.1973520

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1973520

Keywords: triple-negative breast cancer, TRIM33, epigenetics, promoter methylation, gene expression, breast cancer research, TNBC, DNA methylation, Promoter, hypomethylation, associated, elevated

News Source: Nathaniel Bowman. (November 9, 2026). TRIM33 Gene Activity Linked to Aggressive Breast Cancer. Scienmag.

Tags: associatedBreast Cancer ResearchDNA MethylationElevatedepigeneticsgene expressionhypomethylationpromoterpromoter methylationTNBCTRIM33triple-negative breast cancer
Share12Tweet7Share2ShareShareShare1

Related Posts

Celecoxib Relieves Knee Osteoarthritis Pain Across Biological Sex and Obesity Profiles

Celecoxib Relieves Knee Osteoarthritis Pain Across Biological Sex and Obesity Profiles

November 19, 2026
Severe Retinal Degeneration Strikes Most Older Adults With High Myopia in Singapore

Severe Retinal Degeneration Strikes Most Older Adults With High Myopia in Singapore

November 19, 2026

NORD Establishes 49 Rare Disease Centers Across 170 Research Institutions

November 19, 2026

Longitudinal Frailty and Insulin Sensitivity Predict Cardiometabolic Multimorbidity Risk in China

November 19, 2026

POPULAR NEWS

  • Electrical Nerve Stimulation Reduces Acute Postoperative Pain Following Knee Replacement

    Electrical Nerve Stimulation Reduces Acute Postoperative Pain Following Knee Replacement

    29 shares
    Share 12 Tweet 7
  • Thermodynamic Kinetic Modeling Unifies Ammonia Desorption Across Titanium Silicalite-1 Zeolites

    29 shares
    Share 12 Tweet 7
  • Elevated Waist-to-Height Ratio and HbA1c Linked to Higher Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Silver-Functionalized Chitosan Nanoparticles Enhance Platelet-Rich Plasma for Canine Wound Healing

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Ten-Year Study Tracks Monochorionic Dizygotic Twins With Confined Blood Chimerism

Celecoxib Relieves Knee Osteoarthritis Pain Across Biological Sex and Obesity Profiles

Severe Retinal Degeneration Strikes Most Older Adults With High Myopia in Singapore

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.